K.Pesonen*, L.Viinikka*, A.L.Mattila*, A.Koskimies*, J.Perheentupa Children's Hospital, University of Helsinki, Helsinki, Finland EPIDERMAL GROWTH FACTOR (EGF) I N HUMAN BODY FLUIDS To elucidate the distribution and nature of EGF i n human body f l u i d s , we measured immunoreactive EGF (IR-EGF) by a RIA o r a (more sensitive) time-resolved immunofluorometric assay, and evaluated i t s s i z e heterogeneity by s i z e exclusion high performance liquid chromatography. The mean concentration was 80nglml i n urine, 65nglml i n milk, 50nglml i n seminal plasma, 25nglml i n armpit sweat, 1.0 nglml i n breast sweat, 3ng/ml i n s a l i v a , 1.5ng/ m l i n tears, and 0.3nglml i n g a s t r i c juice and third trimester amniotic f l u i d . A l l the f l u i d s contained the standard s i z e 6.2 kilodalton (6.2K) IR-EGF molecule. I t was the only component present i n armpit sweat and g a s t r i c juice. Additionally, we observed the t o t a l of 5 different molecular sizes of IR-EGF, ranging i n approximate molecular weight from 400K to 15K. The standard form made up '90% of the t o t a l IR-EGF i n a l l the f l u i d s except the amniotic f l u i d , where i t s proportion was 71%. A >400K component was present i n milk and amniotic f l u i d , a 300K component i n urine and seminal plasma, a 200K component i n breast sweat, a 80K component i n seminal plasma, saliva and t e a r s and a 15K component i n urine, seminal plasma, and the amniotic f l u i d . I t remains t o be studied whether the larger than standard forms of IR-EGF represent different cleavage products of a common precursor, different t i s s u e specific products, aggregates of EGF, EGF bound t o different proteins, o r several of these. The apparent inability of elevated atrial-natriuretic peptide (ANP) levels to cause natriuresis and diuresis in children with heart failure may be related to a reduced response of target organs to ANP. The cellular effects of ANP seem to be mediated by cGMP a s the second messenger of ANP. Simultaneous measurement of ANP and cGMP has been shown to be a useful tool to study the cellular response to ANP. Therefore, plasma ANP and cGMP levels were measured by radioimmonoassay in 168 healthy childrer and in 47 children with congenital cardiac diseases. In healthy children ANP and cGMP plasma levels were measured in the range of 5-109 pglml (mean 45.5) and 0.2-2.8 pmollml (mean 1.3) respectively. In children with cardiac diseases significantly higher ANP (range 30-980, mean 280 pglml) and cGMP levels (range 0.2-6.0, mean 2.8 pmol/ml) were determined. There was a highly significant correlation between the two in children with cardiac diseases (p<0.001). Furthermore, a significant correlation was found between right atrial pressure and ANP levels (p<0.01) suggesting that atrial stretch is a stimulus for ANP re---lease. The positive correlation between ANP and cGMP levels disagrees with the hypothesis that the cellular response to ANP is diminished in children with cardiac diseases.
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W.Rascher*, T . T u l a s s a y * , U . H e i n r i c h , R.E. L a n e ( I n t r o d . by U . H e i n r i c h ) D e p a r t m e n t of P e d i a t r i c s , U n i v e r s i t y o f H e i d e l b e r g , Fed. Rep. Germany REGULATION OF PLASMA ATRIAL NATRIURETIC PEPTIDE I N CHILDHOOD A t r i a l n a t r i u r e t i c p e p t i d e (ANP) i s r e l e a s e d f r o m c a r d i a c a t r i a i n t o c i r c u l a t i o n a n d i n d u c e s d i u r e s i s a n d n a t r i u r e s i s . We s t u d i e d p l a s m a ANP i n c h i l d r e n u s i n g a s e n s i t i v e r a d i o i m m u n o a s s a y . I n 8 0 n o r m a l c h i l d r e n a e d 4 weeks t o 16 y e a r s ANP a v e r a g e d 27.8+14.0 fmol$ml (E+sD) . N e o n a t e s h a d o n l y s l i g h t l y h i g h z r mean ANP l e v e r s , w h e r e a s i n p r e m a t u r e i n f a n t s a t d a y 1 o f l i f e ANP was u p t o 1 0 t i m e s h i t h a n i n normal c h i l d r e n (252.6+210.0 fmol/ml, n: 1 l F e r These o b s e r v a t i o n s s u g g e s t t h a t volume e x p a n s i o n i s a p o t e n t s t i m u l u s o f ANP r e l e a s e i n c h i l d r e n a n d t h a t t h i s hormone i s i m p o r t a n t i n volume h o m e o s t a s i s . S u p p o r t e d b y D e u t s c h e F o r s c h u n g s g e m e i n s c h a f t Ra 326/1-2 38 F . P e i l l o n x o c .~i a p i~, P . G a r n i e r , A .M.BrandiX, D.Evain B r i o n , D.BressionX, H . S c h e r r e r x , M .Donnadieux INSERM U 223, INSERM U 1 8 8 , FRH, P a r i s , F r a n c e
IN VITRO SIMULTANEOUS RGLEASE OF ENDOGENOUS SOMATOSTATIN AND GROWTH HORMONE FROM HUMAN ADENOMATOUS PITUITARY CELLS D i s p e r s e d c e l l s o b t a i n e d from 1 0 G H -s e c r e t i n g adeno-
mas w e r e s t u d i e d i n p e r i f u s i o n columns, e l u t e 6 w i t h K r e b s R i n g e r b u f f e r . F r a c t i o n s w e r e c o l l e c t e d e a c h 5 min f o r 5 h o u r s a n d a s s a y e d b y RIA f o r GH a n d SRIF c o nt e n t s . B a s a l GH s e c r e t i o n was v a r i a b l e ( 1 0 t o 94 ng/ml/ l o 6 c e l l s ) . W i t h i n t h e f i r s t 1 5 m i n u t e s o f t h e p e r if u s i o n SRIF was d e t e c t e d i n 5 c a s e s ( 5 t o 4 1 pg/ml/106 c e l l s ) . However i n 5 c a s e s a g r e a t r e l e a s e o f SRIF was o n l y o b s e r v e d a f t e r 90 m i n u t e s o r more ( 7 t o 2 5 pg/ml/ 1 0 6 c e l l s ) . I n 2 c a s e s , d u r i n g t h e p e r i f u s i o n , t h e v ar i a t i o n s o f GH and SRIF l e v e l s w e r e s i g n i f i c a n t l y negat i v e l y c o r r e l a t e d ( p < 0 . 0 0 1 ) . C o n c l u s i o n s : 1 ) SRIF i s r e l e a s e d i n v i t r o from human p i t u i t a r y G H -s e c r e t i n g c e l l s , 2) o r i g i n o f SRIF r e l e a s e : i n t e r n a l i z a t i o n o r s y n t h e s i s ? 3) t h e i n v e r s e c o r r e l a t i o n b e t w e e n SRIF a n d GH l e v e l s s u g g e s t s a r o l e o f t h e i n t r a c e l l u l a r SRIF i n t h e r e g u l a t i o n o f GH s e c r e t i o n . Growth hormone (GH) i s a potent stimulator of the multiplicat i o n of pancreatic i s l e t c e l l s . Since in several tissues growth promoting effect of GH seems t o be mediated through IGF production, we have attempted t o characterize IGF-I and binding protein in t o t a l r a t pancreatic extracts and i n neonatal r a t i s l e t c e l l s i n culture. IGF-I was measured in acidic extract a f t e r gel f i lt r a t i o n (biogel P100). RIA used specific antibody (NIAMOO), purified IGF-I (standard Dr Humbel) and I~~~-I G F -I (Dr Van den Brande). IGF-I i s present in the pancreas of 18-21d fetus, neonatal and adult r a t s ranging from .24 t o .07 ng/mg protein. A heavy molecul a r weight protein was characterized. A t neutral PH 1 1 2 5 1~~-I was bound t o t h i s material and the tracer displaced by cold IGF-I a f t e r 4 hr incubation. IGF-I was also characterized in f e t a l r a t i s l e t s in culture maintained for 3 days in serum f r e e medium. I t was found i n the i s l e t s and in the medium together with a heavy molecular weight material with binding properties. Addition of GH in the medium (10 ng/ml) f o r 3 days increased the concentration of both IGF-I and binding protein in the medium.
In conclusion : IGF-I i s present in the r a t pancreas and in the medium of i s l e t s c e l l s i n culture together with a binding protein. Effect of GH on IGF-I production in the medium seems t o indicate t h a t GH multiplicatory a c t i v i t y on O-cell might be mediated through local IGF-I stimulation.
